ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Nine More state To Pay For Cancer Treatment Of CDC-Screened Women.

September 7, 2001

Silicone Implants Not Linked To Increased Risk Of Death

May 25, 2001